Minish Technology Completes 2nd Tokyo Seminar…“50+ New Providers Signed Up”

2026.02.09

A conference room with a lecturer speaking to an audience and images projected on a large screen. Many people are present, and the lecturer is giving a lecture.
Dr. Jung Ho Kang, CEO of Minish Technology, presents his Minish treatment case.

Minish Technology today announced the successful conclusion of the 2nd Tokyo Minish Clinical Case Seminar and Corporate Presentation at its headquarters in Funaisoken, Midtown Tokyo, Japan.

The event was well-received, with 170 attendees, a 70% increase from the first event held in February last year, and the partnership with leading Japanese consulting firm Funai Soken to provide venue and local marketing support.

The most notable change was the speaker lineup. At last year’s seminar, when Minish was still in its infancy, Korean doctors led the seminar, but this year, local Japanese dentists took the podium.

This was possible because the number of Minish provider dental offices in Japan has grown rapidly to 25 over the past year, laying the groundwork for sharing locally accumulated clinical data and operational know-how.

Attendee demographics have also changed. Unlike last year’s opening, which was centered around the opening, this year’s attendees included representatives from medical corporations that operate multiple dental clinics and dentists from major areas of Tokyo.

A scene with a person presenting and attendees in a meeting.
Compared to the inaugural event in February last year, this year’s event had 170 participants, a 70% increase.

The seminar was organized as follows: ▲ Development History and Future Direction of Minish (Mr. Jungho Kang), ▲ Minish Process in Japan (Dr. Gilwoo Ahn, Director of Shinjuku Eye and Ear Department), ▲ Japanese Dental Market and the Role of Minish (Dr. Takaaki Sato, Funaisoken), ▲ Presentation of Local Adoption Cases (Dr. Taito Shimazaki).

“Since the seminar, more than 50 Japanese dentists have applied to become Minish providers, which means that Minish is recognized in Japan as a standalone treatment rather than a complement to existing treatments,” said a Minish Technology representative.

Popular Content

Discover more from 미니쉬테크놀로지 뉴스룸

Subscribe now to keep reading and get access to the full archive.

Continue reading